- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04121702
Outpatient Cardiac Tele-Rehabilitation in a Public Sports Center
Outpatient Cardiac Tele-Rehabilitation in a Public Sports Center Versus Traditional Hospital Model
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiac Rehabilitation (CR) programs show benefits in cardiovascular morbidity and mortality, exercise capacity, risk factors and quality of life. The use of new information and communication technologies (ICT) allows remote monitoring of activity and rhythm, defining a new model of cardiac tele-rehabilitation (CTR) and proving to be safe.
The investigators intend to evaluate a new model of CR in Phase II in acute coronary syndrome (ACS), based on the implementation of the physical exercise program (PEP) in a public sports centre (PSC) with tele-monitoring by means of a wearable electronic device, S-PATCH3-Cardio, to compare the adherence of a PEP based on a CTR-PSC model with the traditional in-hospital program (PEP-H) maintaining the efficacy and safety of the CR program.
Patients with recent stratified ACS of low and / or moderate risk will be included who will be randomly assigned to the PEP-H group who will perform 18 PEP sessions with strength training and cardiorespiratory resistance in a hospital, or a CTR-PSC group that performs the 18 sessions of the PEP with strength training and cardiorespiratory resistance in the PSC.
All patients will perform the rest of the CR program at the hospital that it includes: functional tests, consultations with nurse, cardiologist, rehabilitation doctor, and the educational program, with 10 Workshops in a Cardio-healthy Classroom.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28041
- Recruiting
- Hospital Universitario 12 de Octubre
-
Contact:
- Juan Izquierdo Garcia, Therapist
- Phone Number: +34917792077
- Email: juan.izquierdo@salud.madrid.org
-
Contact:
- Guillermo Moreno Muñoz, Nurse
- Phone Number: +34913908519
- Email: guimoren@ucm.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recent ACS (1-12 months) of low / moderate risk for the realization of a PEP and without physical impediments for it
- Availability of a mobile phone with Android operating system where you can install the S-PATCH3-Cardio application
- Patients who recognize that they are trained to operate the S-PATCH3-Cardio device after being instructed in its operation and perform a 24-hour simulation.
- Signature of informed consent
Exclusion Criteria:
- Baseline ergospirometry that does not reach maximalist criteria (respiratory quotient> 1.1)
- Mental disability
- Associated comorbidity that prevents performing PEP
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: PEP-H
Physical exercise program at a hospital
|
Implementation of a physical exercise program (PEP) with tele-monitoring
|
|
Experimental: PEP-PSC
Physical exercise program with tele-monitoring in a public sport centre
|
Implementation of a physical exercise program (PEP) with tele-monitoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to physical exercise
Time Frame: At the end of the program (6 weeks)
|
Adherence to physical exercise measured by number of physical exercise sessions realized by each patient
|
At the end of the program (6 weeks)
|
|
Functional capacity
Time Frame: At the end of the program (6 weeks)
|
Change of functional capacity measured by cardiopulmonary exercise test
|
At the end of the program (6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose levels
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on the glucose metabolic profile (mg/dL)
|
At the end of the program (6 weeks)
|
|
Glycated hemoglobin levels (HbA1c)
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on the glycated hemoglobin (mg/dL)
|
At the end of the program (6 weeks)
|
|
Low-density lipoprotein (LDL) levels
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on the LDL metabolic profile (mg/dL)
|
At the end of the program (6 weeks)
|
|
High-density lipoprotein (HDL) levels
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on the HDL metabolic profile (mg/dL)
|
At the end of the program (6 weeks)
|
|
Total colesterol levels
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on the total colesterol metabolic profile (mg/dL)
|
At the end of the program (6 weeks)
|
|
Blood pressure levels
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on systolic and diastolic blood pressure levels (mmHg)
|
At the end of the program (6 weeks)
|
|
Smoking
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on smoking status (cessation of smoking)
|
At the end of the program (6 weeks)
|
|
Weight
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on weight (kg)
|
At the end of the program (6 weeks)
|
|
Abdominal perimeter
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on abdominal perimeter (cm)
|
At the end of the program (6 weeks)
|
|
Body Mass Index (BMI)
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on body mass index (weight in kg and height in meters will be combined to calculate BMI in kg/m˄2)
|
At the end of the program (6 weeks)
|
|
Adherence to Mediterranean Diet
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on mediterranean dietary habits measured ussing the Mediterranean Diet Assessment Scale (MEDAS) which is constituted by 14 ítems with questions concerning dietary habits related to the medditerranean dietary style.
Minimum score: 0, maximum score: 14.
Values over 9 are corresponded to good adherence to mediterranean diet, values under 9 are considered to be bad adherence.
|
At the end of the program (6 weeks)
|
|
Phisical exercise profile
Time Frame: At the end of the program (6 weeks)
|
Evaluate changes on level of physical activity measured ussing the International Physical Activity Questionnaire (IPAQ). It asks about three specific types of activity undertaken in the four domains: leisure time physical activity, domestic and gardening (yard) activities, work-related physical activity, transport-related physical activity. The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous-intensity activities. Computation of the total score for the form requires summation of the duration (in minutes) and frequency (days) of walking, moderate-intensity and vigorous-intensity activities. Maximun value: the sum total of all Walking, Moderate and Vigorous time variables greater than 960 minutes (16 hours). Mínimum value: Only values of 10 or more minutes of activity should be included in the calculation of summary scores. Responses of less than 10 minutes [and their associated days] should be re-coded to 'zero' |
At the end of the program (6 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Juan Izquierdo Garcia, Therapist, Hospital Universitario 12 de Octubre
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- e-CARCEX
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Germany, Finland, Sweden, Switzerland, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Samsung Medical CenterNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
-
Tongji HospitalRecruiting
Clinical Trials on Cardiac Rehabilitation
-
Wake Forest University Health SciencesRecruitingCardiac AmyloidosisUnited States
-
Lawson Health Research InstituteHeart and Stroke Foundation of OntarioCompleted
-
Atlas UniversityCompletedCoronary Artery Disease | Coronary Artery Bypass Graft SurgeryTurkey (Türkiye)
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); AstraZenecaCompletedMyocardial Infarction | Coronary Disease | Unstable AnginaCanada
-
Cairo UniversityNational Heart Institute, EgyptCompletedChronic Heart FailureEgypt
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; Johns Hopkins University; Mayo... and other collaboratorsRecruitingMyocardial Infarction | Coronary Artery Disease | Heart Valve Diseases | Angina, Stable | Heart Failure, Systolic | Heart TransplantUnited States
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Heart DiseaseUnited States
-
Samsung Medical CenterCompletedCongenital Heart DiseaseKorea, Republic of
-
Fundación Pública Andaluza para la Investigación...UnknownHomebased Cardiac Rehabilitation Program After Ischemic Heart DiseaseSpain